Ivermectin: Still on a Losing Streak as COVID-19 Treatment
WASHINGTON — There were no differences in relief from mild-to-moderate COVID-19 symptoms for patients on ivermectin versus placebo, according to the ongoing ACTIV-6 trial. Among>1,000 vaccinated and unvaccinated patients, the median time to recovery was 12 days for those in the ivermectin group and 13 days in the placebo group, reported Matthew McCarthy, MD, of …
Ivermectin: Still on a Losing Streak as COVID-19 Treatment Read More »









